Ligand binding to the human MT2 melatonin receptor: The role of residues in transmembrane domains 3, 6, and 7

被引:22
作者
Mazna, P
Berka, K
Jelinkova, I
Balik, A
Svoboda, P
Obsilova, V
Obsil, T
Teisinger, J
机构
[1] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic
[2] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic
关键词
MT2 melatonin receptor; site-directed mutagenesis; homolog modeling; G-protein-coupled receptor;
D O I
10.1016/j.bbrc.2005.05.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To better understand the mechanism of interactions between G-protein-coupled melatonin receptors and their ligands, our previously reported homology model of human MT2 receptor with docked 2-iodomelatonin was further refined and used to select residues within TM3, TM6, and TM7 potentially important for receptor ligand interactions, Selected residues Were mutated and radioligand-binding assay was used to test the binding affinities of hMT2 receptors transiently expressed in HEK293 cells. Our data demonstrate that residues N268 and A275 in TM6 as well as residues V291 and L295 in TM7 are essential for 2-iodomelatonin binding to the hMT2 receptor, while TM3 residues M120, G121. V124. and H25 may participate in binding of other receptor agonists and/or antagonists. Presented data also hint Lit possible specific interaction between the side-chain of Y188 in second extracellular loop and N-acetyl group of 2-iodomelatonin. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:726 / 734
页数:9
相关论文
共 28 条
  • [11] MOLECULAR-SURFACE RECOGNITION - DETERMINATION OF GEOMETRIC FIT BETWEEN PROTEINS AND THEIR LIGANDS BY CORRELATION TECHNIQUES
    KATCHALSKIKATZIR, E
    SHARIV, I
    EISENSTEIN, M
    FRIESEM, AA
    AFLALO, C
    VAKSER, IA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) : 2195 - 2199
  • [12] Important amino acids for the function of the human MT1 melatonin receptor
    Kokkola, T
    Foord, SM
    Watson, MA
    Vakkuri, O
    Laitinen, JT
    [J]. BIOCHEMICAL PHARMACOLOGY, 2003, 65 (09) : 1463 - 1471
  • [13] The immunotherapeutic potential of melatonin
    Maestroni, GJM
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (03) : 467 - 476
  • [14] MASANA MI, 2001, SCI STKE, pPE39
  • [15] Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding
    Mazna, P
    Obsilova, V
    Jelinkova, I
    Balik, A
    Berka, K
    Sovova, Z
    Ettrich, R
    Svoboda, P
    Obsil, T
    Teisinger, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 91 (04) : 836 - 842
  • [16] Identification of the melatonin-binding site MT3 as the quinone reductase 2
    Nosjean, O
    Ferro, M
    Cogé, F
    Beauverger, P
    Henlin, JM
    Lefoulon, F
    Fauchère, JL
    Delagrange, P
    Canet, E
    Boutin, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 31311 - 31317
  • [17] Crystal structure of rhodopsin: A G protein-coupled receptor
    Palczewski, K
    Kumasaka, T
    Hori, T
    Behnke, CA
    Motoshima, H
    Fox, BA
    Le Trong, I
    Teller, DC
    Okada, T
    Stenkamp, RE
    Yamamoto, M
    Miyano, M
    [J]. SCIENCE, 2000, 289 (5480) : 739 - 745
  • [18] Role of the extracellular loops of the thyrotropin-releasing hormone receptor: Evidence for an initial interaction with thyrotropin-releasing hormone
    Perlman, JH
    Colson, AO
    Jain, R
    Czyzewski, B
    Cohen, LA
    Osman, R
    Gershengorn, MC
    [J]. BIOCHEMISTRY, 1997, 36 (50) : 15670 - 15676
  • [19] The chronobiotic properties of melatonin
    Pévet, P
    Bothorel, B
    Slotten, H
    Saboureau, M
    [J]. CELL AND TISSUE RESEARCH, 2002, 309 (01) : 183 - 191
  • [20] Reiter R J, 1980, Endocr Rev, V1, P109